Cargando…

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies

PURPOSE: Anti-KIR monoclonal antibodies (mAbs) can enhance the antitumor responses of natural killer (NK) cells. We evaluated the safety of the anti-KIR2D mAb lirilumab in patients with various cancers. EXPERIMENTAL DESIGN: Thirty-seven patients with hematological malignancies (n = 22) or solid tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vey, Norbert, Karlin, Lionel, Sadot-Lebouvier, Sophie, Broussais, Florence, Berton-Rigaud, Dominique, Rey, Jérôme, Charbonnier, Aude, Marie, Delphine, André, Pascale, Paturel, Carine, Zerbib, Robert, Bennouna, Jaafar, Salles, Gilles, Gonçalves, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915148/ https://www.ncbi.nlm.nih.gov/pubmed/29707140 http://dx.doi.org/10.18632/oncotarget.24832

Ejemplares similares

Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
por: Sola, Caroline, et al.
Publicado: (2013)

S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMAS
por: Demaria, Olivier, et al.
Publicado: (2023)

Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas
por: Marie-Cardine, Anne, et al.
Publicado: (2013)

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
por: Hanna, Glenn J., et al.
Publicado: (2022)

Luminescent Iridium Complex-Peptide Hybrids (IPHs) for Therapeutics of Cancer: Design and Synthesis of IPHs for Detection of Cancer Cells and Induction of Their Necrosis-Type Cell Death
por: Masum, Abdullah-Al, et al.
Publicado: (2018)

Ligilactobacillus salivarius 2102-15 complete genome sequence data
por: Karlyshev, Andrey V., et al.
Publicado: (2023)

Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients
por: Vergori, Alessandra, et al.
Publicado: (2021)

KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis
por: Wunsch, Marie, et al.
Publicado: (2014)

IPhO: list of winners in 1st-40th international physics olympiads
por: Gorzkowski, Waldemar, et al.
Publicado: (2010)

Genomics is changing personal healthcare and medicine: the dawn of iPH (individualized preventive healthcare)
por: Mehrian-Shai, Ruty, et al.
Publicado: (2015)

2102. Peripherally Inserted Central Catheter (PICC) Placement: Indications and Financial Impact
por: Cheronis, Nicholas, et al.
Publicado: (2018)

Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity
por: Imamura, Michie, et al.
Publicado: (2020)

Targeting MICA with therapeutic antibodies for the treatment of cancer
por: Bonnafous, Cécile, et al.
Publicado: (2013)

Lirilumab and Avelumab Enhance Anti-HPV+ Cervical Cancer Activity of Natural Killer Cells via Vav1-Dependent NF-κB Disinhibition
por: Liu, Hongli, et al.
Publicado: (2022)

The importance of cell culture parameter standardization: an assessment of the robustness of the 2102Ep reference cell line
por: Kusena, James Willard Tonderai, et al.
Publicado: (2021)

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody‐dependent (AD) NK cell activation and ADCC
por: Lisovsky, Irene, et al.
Publicado: (2019)

Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells
por: van Agthoven, Ton, et al.
Publicado: (2015)

Prevalence of stroke in Pakistan: Findings from Khyber Pakhtunkhwa integrated population health survey (KP-IPHS) 2016-17
por: Sherin, Akhtar, et al.
Publicado: (2020)

Long-Term Exposure to Particulate Matter and Mortality from Cardiovascular Diseases in Japan: The Ibaraki Prefectural Health Study (IPHS)
por: Takeuchi, Ayano, et al.
Publicado: (2021)

Diabetes Mellitus Modifies the Association of Serum Triglycerides with Ischemic Cardiovascular Disease Mortality: The Ibaraki Prefectural Health Study (IPHS)
por: Yamagishi, Kazumasa, et al.
Publicado: (2022)

KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors
por: Morales-Estevez, Cristina, et al.
Publicado: (2016)

Characterization of KIR (+) NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA‐C
por: Meazza, Raffaella, et al.
Publicado: (2022)

Novel Radioiodinated and Radiofluorinated Analogues of FT-2102 for SPECT or PET Imaging of mIDH1 Mutant Tumours
por: Weber, Valérie, et al.
Publicado: (2022)

PB2102: IMPACT OF AUTOLOGOUS STEM CELL TRASPLANTATION IN AL AMYLOIDOSIS. EXPERIENCE IN A SINGLE TERTIARY HOSPITAL
por: Alonso, Elena Alejo, et al.
Publicado: (2023)

Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML
por: de Botton, Stéphane, et al.
Publicado: (2023)

Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas
por: Schmitt, Christian, et al.
Publicado: (2017)

Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes
por: Falco, Michela, et al.
Publicado: (2022)

The Arizona Intimate Partner Homicide (AzIPH) Study: a Step toward Updating and Expanding Risk Factors for Intimate Partner Homicide
por: Messing, Jill Theresa, et al.
Publicado: (2021)

Comparative genomic analysis of the DUF71/COG2102 family predicts roles in diphthamide biosynthesis and B12 salvage
por: de Crécy-Lagard, Valérie, et al.
Publicado: (2012)

Rhinitis, sinusitis and ocular disease – 2102. The activities of allergy pot as a patient group in Japan: developing treatment guidelines
por: Kuriyama, Mariko, et al.
Publicado: (2013)

2102. Common co-occurence in the respiratory tract of Mucorales with Gram-negative rods in patients with hematologic malignancy and sinopulmonary mucormycosis
por: Egge, Stephanie L, et al.
Publicado: (2022)

Impact of Donor-Specific anti-HLA Antibodies and Donor KIR Characteristics in Haploidentical HSCT for Beta-Thalassemia
por: Andreani, Marco, et al.
Publicado: (2017)

Production of type I interferons: plasmacytoid dendritic cells and beyond
por: Asselin-Paturel, Carine, et al.
Publicado: (2005)

A novel antibody combination to identify KIR2DS2(high) natural killer cells in KIR2DL3/L2/S2 heterozygous donors
por: Blunt, Matthew D., et al.
Publicado: (2019)

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients
por: Gallagher, Michael F, et al.
Publicado: (2009)

PReS-FINAL-2102: Comparison of sensitivity and specificity of MAS and HLH diagnostic guidelines in 362 children with MAS complicating systemic JIA
por: Davì, S, et al.
Publicado: (2013)

2102. Does Monitoring Procalcitonin Levels in Septic and Septic Shock Patients Decrease the Use of Antibiotics and Predict Length of Hospital Stay?
por: Bilbe, Sarah E, et al.
Publicado: (2019)

Characterisation of mouse monoclonal antibodies against rhesus macaque killer immunoglobulin-like receptors KIR3D
por: Hermes, Meike, et al.
Publicado: (2012)

A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses
por: Ovsyannikova, Inna G., et al.
Publicado: (2017)

Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review
por: Navas-Madroñal, Miquel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hq2bs20s41l8vni2i81enufnc7